HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francis Vacherot Selected Research

Transforming Growth Factors (Transforming Growth Factor)

7/2011Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francis Vacherot Research Topics

Disease

28Prostatic Neoplasms (Prostate Cancer)
04/2022 - 07/2002
17Neoplasms (Cancer)
04/2022 - 07/2002
4Carcinoma (Carcinomatosis)
05/2015 - 03/2004
2Prostatic Intraepithelial Neoplasia
01/2021 - 03/2009
2Inflammation (Inflammations)
07/2011 - 12/2008
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
07/2011 - 03/2008
2Disease Progression
07/2010 - 05/2003
1COVID-19
01/2021
1Prostatitis
07/2011
1Bone Fractures (Bone Fracture)
09/2004
1Urinary Bladder Neoplasms (Bladder Cancer)
03/2004
1Starvation
11/2002
1Hypoxia (Hypoxemia)
07/2002

Drug/Important Bio-Agent (IBA)

11AndrogensIBA
12/2017 - 07/2002
7Hormones (Hormone)IBA
01/2021 - 07/2002
7Proteins (Proteins, Gene)FDA Link
05/2015 - 07/2002
4Biomarkers (Surrogate Marker)IBA
04/2022 - 11/2010
4Prostate-Specific Antigen (Semenogelase)IBA
05/2015 - 03/2009
3Androgen Receptors (Androgen Receptor)IBA
01/2021 - 10/2006
3Docetaxel (Taxotere)FDA Link
10/2016 - 09/2004
3beta CateninIBA
06/2005 - 11/2002
2Estrogens (Estrogen)FDA Link
08/2015 - 03/2008
2LigandsIBA
07/2013 - 10/2006
2LuciferasesIBA
04/2010 - 06/2005
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2008 - 10/2007
2Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2005 - 03/2004
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2005 - 03/2004
2Pharmaceutical PreparationsIBA
02/2005 - 03/2004
2nitrosulindacIBA
10/2004 - 03/2004
1NucleolinIBA
04/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Long Noncoding RNAIBA
01/2022
1ParaffinIBA
01/2022
1Formaldehyde (Formol)FDA Link
01/2022
1Circular RNAIBA
01/2022
1Phenobarbital (Luminal)FDA Link
01/2021
1NucleoproteinsIBA
10/2016
1NucleophosminIBA
10/2016
1Kazal Pancreatic Trypsin InhibitorIBA
05/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2011
1AntigensIBA
03/2011
1TubulinIBA
11/2010
1taxaneIBA
11/2010
1cyclopamineIBA
04/2010
1EstroneFDA Link
03/2008
1estrone sulfate (Evex)FDA Link
03/2008
1NF-kappa B (NF-kB)IBA
10/2007
1Interleukin-6 (Interleukin 6)IBA
10/2007
1Messenger RNA (mRNA)IBA
10/2006
1TCF Transcription FactorsIBA
10/2006
1SteroidsIBA
10/2006
1ErbB Receptors (EGF Receptor)IBA
05/2006
1Tyrosine Kinase InhibitorsIBA
05/2006
1Mitogen-Activated Protein KinasesIBA
05/2006
1Gefitinib (Iressa)FDA Link
05/2006
1Finasteride (Propecia)FDA LinkGeneric
11/2005
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2005
1Diphosphonates (Bisphosphonates)IBA
09/2004
1Taxoids (Taxanes)IBA
09/2004
1Zoledronic Acid (Zometa)FDA Link
09/2004
1Sulindac (Copal)FDA LinkGeneric
03/2004
1Phorbol EstersIBA
11/2002
1Nucleic AcidsIBA
07/2002
1DNA (Deoxyribonucleic Acid)IBA
07/2002
1Complementary DNA (cDNA)IBA
07/2002
1Transcription Factors (Transcription Factor)IBA
07/2002
1Amino AcidsFDA Link
07/2002
1Oxygen (Dioxygen)IBA
07/2002

Therapy/Procedure

7Therapeutics
10/2016 - 07/2002
3Prostatectomy (Retropubic Prostatectomy)
10/2013 - 07/2010
3Castration
07/2013 - 04/2010
1Aftercare (After-Treatment)
11/2010
1Drug Therapy (Chemotherapy)
11/2010
1Blood Transfusion (Blood Transfusions)
09/2004